SUPN Stock-Based Compensation
Supernus Pharmaceuticals Inc · Stock-Based Compensation
SUPN Stock-Based Compensation
Latest reported$58.00Mperiod ending
SUPN Stock-Based Comp ($74.10K → $58.00M)
Annual stock-based compensation
High-resolution chart · PNG
SUPN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 33,051,000 | |
| 27,755,000 | |
| 26,759,000 | |
| 17,568,000 | |
| 17,910,000 | |
| 16,561,000 | |
| 14,846,000 | |
| 11,291,000 | |
| 8,433,000 | |
| 5,926,000 | |
| 4,231,000 | |
| 2,716,000 | |
| 1,913,000 | |
| 443,000 | |
| -82,000 | |
| 297,000 | |
| 111,000 | |
| 99,000 | |
| 74,100 |